2010Zhongguo yaofangRequires access

Study on Bioequivalence of 2 Kinds of Azithromycin Preparations in Healthy Volunteers

Haisheng You, Wang Pei-xian, Xiuqin Wang

Open publisher page 0 citations

Abstract

OBJECTIVE:To study the bioequivalence of 2 kinds of azithromycin preparations.METHODS:18 male healthy volunteers were enrolled in randomized controlled crossover design and given a signal oral dose of azithromycin dispersible tablet(test preparation) and azithromycin capsule(reference preparation).Plasma concentration of azithromycin was detected by microbiological method and pharmacokinetic parameters were calculated using 3p97 software.Bioequivalence of 2 kinds of azithromycin preparations were evaluated.RESULTS:Main pharmacokinetic parameters of test preparation vs.reference preparation were as follows:Cmax(0.34±0.06)μg·mL-1 vs.(0.30±0.06)μg·mL-1;tmax(2.40±0.48)h vs.(2.29±0.55)h;AUC0~144(2.80±0.80)μg·h·mL-1 vs.(2.82±1.44)μg·h·mL-1;AUC0~∞(2.95±0.67) μg·h·mL-1 vs.(2.91±1.68) μg·h·mL-1.There was no significant difference between pharmacokinetic parameters of 2 kinds of preparations(P0.05).The relative bioavailability of azithromycin dispersible tablets was(99.29±3.85)%.CONCLUSION:2 kinds of azithromycin preparations are bioequivalent.

About this research paper

What this paper is about

OBJECTIVE:To study the bioequivalence of 2 kinds of azithromycin preparations.METHODS:18 male healthy volunteers were enrolled in randomized controlled crossover design and given a signal oral dose of azithromycin dispersible tablet(test preparation) and azithromycin capsule(reference preparation).Plasma concentration of azithromycin was detected by microbiological method and pharmacokinetic parameters were calculated using 3p97 software.Bioequivalence of 2 kinds of azithromycin preparations were evaluated.RESULTS:Main pharmacokinetic parameters of test preparation vs.reference preparation were as follows:Cmax(0.34±0.06)μg·mL-1 vs.(0.30±0.06)μg·mL-1;tmax(2.40±0.48)h vs.(2.29±0.55)h;AUC0~144(2.80±0.80)μg·h·mL-1 vs.(2.82±1.44)μg·h·mL-1;AUC0~∞(2.95±0.67) μg·h·mL-1 vs.(2.91±1.68) μg·h·mL-1.There was no significant difference between pharmacokinetic parameters of 2 kinds of preparations(P0.05).The relative bioavailability of azithromycin dispersible tablets was(99.29±3.85)%.CONCLUSION:2 kinds of azithromycin preparations are bioequivalent.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

OBJECTIVE:To study the bioequivalence of 2 kinds of azithromycin preparations.METHODS:18 male healthy volunteers were enrolled in randomized controlled crossover design and given a signal oral dose of azithromycin dispersible tablet(test preparation) and azithromycin capsule(reference preparation).Plasma concentration of azithromycin was detected by microbiological method and pharmacokinetic parameters were calculated using 3p97 software.Bioequivalence of 2 kinds of azithromycin preparations were evaluated.RESULTS:Main pharmacokinetic parameters of test preparation vs.reference preparation were as follows:Cmax(0.34±0.06)μg·mL-1 vs.(0.30±0.06)μg·mL-1;tmax(2.40±0.48)h vs.(2.29±0.55)h;AUC0~144(2.80±0.80)μg·h·mL-1 vs.(2.82±1.44)μg·h·mL-1;AUC0~∞(2.95±0.67) μg·h·mL-1 vs.(2.91±1.68) μg·h·mL-1.There was no significant difference between pharmacokinetic parameters of 2 kinds of preparations(P0.05).The relative bioavailability of azithromycin dispersible tablets was(99.29±3.85)%.CONCLUSION:2 kinds of azithromycin preparations are bioequivalent.

Key concepts: Bioequivalence, Azithromycin, Cmax, Pharmacokinetics, Bioavailability, Crossover study, Capsule, Medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
Study on Bioequivalence of 2 Kinds of Azithromycin Preparations in Healthy Volunteers — Research Paper | ScholarLens